Pacira BioSciences Q4 2022 Earnings Preview
- Pacira BioSciences (NASDAQ:PCRX) is scheduled to announce Q4 earnings results on Tuesday, February 28th, before market open.
- The consensus EPS Estimate is $0.83 (-14.4% Y/Y) and the consensus Revenue Estimate is $173.32M (+8.9% Y/Y).
- Over the last 2 years, PCRX has beaten EPS estimates 50% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 8 downward. Revenue estimates have seen 0 upward revisions and 7 downward.